TY - JOUR T1 - A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19) JF - medRxiv DO - 10.1101/2020.02.14.20023028 SP - 2020.02.14.20023028 AU - Shuai Wang AU - Bo Kang AU - Jinlu Ma AU - Xianjun Zeng AU - Mingming Xiao AU - Jia Guo AU - Mengjiao Cai AU - Jingyi Yang AU - Yaodong Li AU - Xiangfei Meng AU - Bo Xu Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/18/2020.02.14.20023028.abstract N2 - Background To control the spread of Corona Virus Disease (COVID-19), screening large numbers of suspected cases for appropriate quarantine and treatment measures is a priority. Pathogenic laboratory testing is the diagnostic gold standard but it is time consuming with significant false positive results. Fast and accurate diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we hypothesized that deep learning methods might be able to extract COVID-19’s graphical features and provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control.Methods We collected 453 CT images of pathogen-confirmed COVID-19 cases along with previously diagnosed with typical viral pneumonia. We modified the Inception migration-learning model to establish the algorithm, followed by internal and external validation.Findings The internal validation achieved a total accuracy of 82·9% with specificity of 80·5% and sensitivity of 84%. The external testing dataset showed a total accuracy of 73·1% with specificity of 67% and sensitivity of 74%.Interpretation These results demonstrate the proof-of-principle for using artificial intelligence to extract radiological features for timely and accurate COVID-19 diagnosis.Funding No funding is involved in the execution of the project.Evidence before this study Fast and accurate screening large numbers of cases with viral pneumonia symptoms for appropriate quarantine and treatment measures is a priority to control the spread of Corona Virus Disease (COVID-19). Pathogenic laboratory testing is the diagnostic gold standard but it is time-consuming with significant false positive results. Computed tomography (CT) is also a major diagnostic tool for COVID-19. Although typical CT images may help early screening of suspected cases, the images of various viral pneumonias are similar and they overlap with other infectious and inflammatory lung diseases. Artificial intelligent technologies such as deep learning might be able to extract COVID-19’s graphical features and provide a clinical diagnosis. However, there is no published work exploring this possibility.Added value of this study Our study represents the first study to apply artificial intelligence technologies to CT images for effectively screening for COVID-19. We employed a modified Inception migration-learning model to establish the algorithm. The internal validation achieved a total accuracy of 82·9% with specificity of 80·5% and sensitivity of 84%. The external testing dataset showed a total accuracy of 73·1% with specificity of 67% and sensitivity of 74%. The time for each case is about 2 seconds and can be done remotely via a shared public platform.Implications of all the available evidence To control the outbreak of COVID-19, it is crucial to develop fast, accurate, safe and non-invasive methods for early diagnosis. We present a proof-of-principle of such as method. We believe that with more data included for further optimization and testing, the accuracy, specificity and sensitivity can be improved. Such a platform can be used to assist clinical diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available. https://ai.nscc-tj.cn/thai/deploy/public/pneumonia_ct ER -